Advertisement

Topics

EpiPen-maker Mylan got 9% of its earnings last year from coal

11:02 EDT 21 Jun 2017 | Topix

But a non-pharmaceutical offering - refined coal - has quietly generated hundreds of millions of dollars of tax credits for the company over the last six years that have boosted its bottom line, according to a Reuters review of company filings. Since 2011, Mylan has bought 99 percent stakes in five companies across the U.S. that own plants which process coal to reduce smog-causing emissions.

Original Article: EpiPen-maker Mylan got 9% of its earnings last year from coal

NEXT ARTICLE

More From BioPortfolio on "EpiPen-maker Mylan got 9% of its earnings last year from coal"

Advertisement
Quick Search
Advertisement
Advertisement